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Background. The prevalence of kidney stone disease in the
United States is progressively increasing, paralleling the grow-
ing rate of obesity. Uric acid nephrolithiasis, a condition asso-
ciated with a low urinary pH, has been linked to obesity and
insulin resistance. Based on these observations, we hypoth-
esized that urinary pH may be inversely associated to body
weight in nephrolithiasis.
Methods. Data were retrieved from 4883 patients with
nephrolithiasis who underwent ambulatory evaluation at two
established stone clinics in Dallas and Chicago. The patients
collected 24-hour urine samples on an outpatient basis, while
avoiding any drug that could alter urinary pH. Patients were
divided in increasing sextiles of body weight, and urinary pH
was adjusted for urinary creatinine and for age.
Results. Urinary pH had a strong, graded inverse association
with body weight. Urinary creatinine and age were both found
to be significant covariates of urinary pH, while gender was not
a significant independent variable after adjustment for urinary
creatinine. Mean 24-hour urinary pH, adjusted for age and uri-
nary creatinine, were 6.09, 6.04, 6.01, 5.99, 5.97, and 5.91 for
sextiles of body weight in increasing order from Dallas (P for
linear trend <0.0001), and 6.18, 6.10, 6.04, 6.02, 5.97, and 5.88
for the sextiles from Chicago (P for linear trend <0.0001).
Conclusion. We conclude that urinary pH is inversely related
to body weight among patients with stones. The results confirm
the previously proposed scheme that obesity may sometimes
cause uric acid nephrolithiasis by producing excessively acid
urine due to insulin resistance.
The prevalence of kidney stone disease is increasing in
the United States as well as in other countries [1–3], paral-
leling the escalating rate of obesity in many nations [4–6].
This finding has led some authors to speculate whether
obesity has a role in the development of nephrolithia-
sis [7–9]. The prevalence and incidence of stone disease
have been reported to be associated with body weight
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and body mass index (BMI) [9]. However, these epidemi-
ologic studies did not distinguish between the different
types of kidney stones, evaluate the biochemical data, or
consider underlying biochemical mechanisms.
Recent studies have shown that patients with recur-
rent uric acid nephrolithiasis display metabolic and clini-
cal features characteristic of the metabolic syndrome [10,
11]. Moreover, a recent retrospective analysis showed
that patients with kidney stones who suffer from type
2 diabetes mellitus have a higher prevalence of uric acid
nephrolithiasis than in a general population of patients
with renal stones [12].
A persistently low urinary pH (<5.5, the pKa for
uric acid) is a distinctive feature of idiopathic uric acid
nephrolithiasis previously termed as “gouty diathesis”
[13, 14]. In such an unduly acidic urinary environment, the
concentration of sparingly soluble undissociated uric acid
increases, resulting in the formation of uric acid stones by
direct precipitation [15]. Calcium oxalate stones may also
develop by heterogeneous nucleation of calcium oxalate
by uric acid [16–18].
Based on the above observations, it has been proposed
that resistance to insulin action in the kidney (“renal in-
sulin resistance”) may lead to excessive urinary acidifi-
cation and formation of uric acid stones [10, 11, 19]. The
purpose of the current study was to test this hypothe-
sis by examining the relationship between urinary pH
(a surrogate of renal insulin resistance) and body weight
(a surrogate of peripheral insulin resistance) in a large
population of kidney stone formers from two well-
established kidney stone centers in the United States.
METHODS
Patient data
Data were derived from patients who underwent am-
bulatory evaluation for nephrolithiasis in two estab-
lished stone clinics, the University of Texas Southwest-
ern Medical Center (Dallas group) and at the Univer-
sity of Chicago (Chicago group). To avoid selection bias,
all adult patients (age ≥ 18 years old) who were eval-
uated between the years 1975 and 2002 in Dallas and
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between 1969 and March 2003 in Chicago were included.
A 24-hour urinary pH was routinely measured in both
groups. In the Dallas group, both body weight and height
were measured, but not in all patients. In the Chicago
group, body weight was routinely obtained but height
was not obtained. This retrospective data analysis was
based on a total of 4883 patients, 3168 from Chicago and
1715 from Dallas, in whom 24-hour urinary pH and body
weight were available.
Study protocol
In the Dallas group, two 24-hour urine samples were
collected while the patients consumed their usual diet,
and one 24-hour urine sample was obtained while subjects
were maintained on a diet restricted in calcium, sodium,
and oxalate. In Chicago, three 24-hour urine samples on a
random diet were collected. At the time of collection, the
subjects were not receiving any medications that could
alter their urinary pH, such as alkali therapy with potas-
sium citrate, nor taking any treatment for kidney stone
disease, such as thiazide diuretics or allopurinol. Urine
samples were collected under refrigeration or utilizing
an ice chest. Urinary pH was obtained using a pH elec-
trode. Urinary creatinine was measured by the picric acid
method. The weight of the patient was determined at the
time of delivery of the urinary samples.
Statistical methods
The mean urinary pH used in the analysis was calcu-
lated for each patient from one restricted and two random
urine samples from the Dallas group and three 24-hour
urine samples from the Chicago group. Patients from each
group were separated into six categories by increasing
sextiles of body weight. Data from the two groups were
analyzed separately. Analysis of covariance models were
used to compare urinary pH between the weight sextiles
while adjusting for the potential confounding effects of
covariates. Age, gender, and urinary creatinine were as-
sessed as covariates. Tests of linear trend were conducted
by one-way analysis of variance.
For the data from the Dallas group, a subgroup anal-
ysis was also performed using the same statistical meth-
ods, after excluding 219 patients with conditions known
to affect urinary pH (inflammatory bowel disease, renal
tubular acidosis, infection stones, and primary hyper-
parathyroidism). In addition, data from the random diet
and restricted diet were analyzed separately, and the as-
sociation of urinary pH with BMI was assessed. More-
over, in order to ascertain whether a high acid ash diet
might have contributed to low urinary pH, data for the
restricted diet was further analyzed after adjusting for
urinary sulfate and phosphorus, markers of dietary acid
ash content.
Table 1. Demographic information
Dallas Chicago
Patients number 1715 3168
Gender men/women 1130/585 2121/1047
Age years 43 ± 13 44 ± 13
Range (18–78) (20–87)
Weight kg 79 ± 19 80 ± 18
Range (36–204) (30–210)
Data are presented as mean ± standard deviation.
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Fig. 1. Urinary pH by sextile of body weight. Vertical bars indicate
mean ± SE.
Statistical analysis was performed with SAS version 8.2
(SAS Institute, Cary, NC, USA).
RESULTS
The demographic information of the group at each
site is summarized in Table 1. The patients from Dallas
comprised 1130 men and 585 women, while those from
Chicago included 2121 men and 1047 women. The mean
age was 43 years for the Dallas group and 44 years for the
Chicago group, and the mean weight was 79 kg for the
Dallas group and 80 kg for the Chicago group. The sex-
tiles of body weight were similar between the two groups.
In both Dallas and Chicago, unadjusted urinary pH
displayed a stepwise decrease with increasing sextiles of
body weight (Fig. 1). The mean 24-hour urinary pH values
for the respective sextiles were 6.16, 6.07, 6.01, 5.97, 5.94,
and 5.86 for the Dallas group (P for linear trend <0.0001),
and 6.22, 6.12, 6.04, 6.00, 5.94, and 5.84 for the Chicago
group (P for linear trend <0.0001).
1424 Maalouf et al: Urinary pH and body weight in nephrolithiasis
5.8
5.9
6.0
6.2
6.1
6.3
Ur
in
ar
y 
pH
, a
dju
ste
d f
or 
ag
e a
nd
 ur
ina
ry 
cre
ati
nin
e
1 2 3 4 5 6
<61 kg
N = 285
61–70
N = 279
70–77
N = 310
77–84
N = 275
84–95
N = 281
>95 kg
N = 285
<61 kg
N = 467
61–70
N = 503
70–78
N = 573
78–85
N = 498
85–96
N = 581
>96 kg
N = 546
Dallas
Chicago
Dallas
Chicago
Sextile of weight
Fig. 2. Urinary pH adjusted for age and urinary creatinine by sextile
of body weight. Vertical bars indicate mean ± SE.
In the analysis of covariance models, urinary creatinine
and age were found to be significant covariates of urinary
pH at both sites. After adjustment for urinary creatinine,
gender was not a significant independent variable. In or-
der to control for the effects of age and urinary creatinine
on urinary pH, data analysis was repeated after adjust-
ing for these two variables, and the inverse relationship
between urinary pH and body weight persisted. The ad-
justed mean 24-hour urinary pHs were 6.09, 6.04, 6.01,
5.99, 5.97, and 5.91, for the sextiles of body weight in in-
creasing order from the Dallas group (P for linear trend
<0.0001), and 6.18, 6.10, 6.04, 6.02, 5.97, and 5.88, from
the Chicago group (P for linear trend <0.0001) (Fig. 2).
After excluding data from 219 patients with conditions
that could affect urinary pH, the same association was
found between adjusted urinary pH and body weight
(P for linear trend <0.0001). Moreover, the same step-
wise reduction in urinary pH was displayed with increas-
ing body weight, when only the data from the restricted
urine samples were employed: For the data on the re-
stricted diet, values for urinary pH, adjusted for age
and urinary creatinine, were 6.11, 6.03, 5.96, 5.97, 5.89,
and 5.84 for sextiles of body weight in increasing order
(P for linear trend <0.0001). Values for urinary pH ad-
justed for age, urinary creatinine, sulfate, and phospho-
rus were 6.13, 6.02, 5.95, 5.96, 5.89, and 5.83 for sextiles
of body weight in increasing order (P for linear trend
<0.0001). Urinary pH displayed a similar but less steep
stepwise decrease with increasing BMI. For all three urine
samples from Dallas, mean values for urinary pH, ad-
justed for age and urinary creatinine, were 6.05, 6.04, 6.01,
6.01, 5.96, and 5.94 for sextiles of BMI in increasing order
(P for linear trend = 0.003).
DISCUSSION
The purpose of our study was to examine the asso-
ciation between urinary pH and body weight in a large
number of patients with nephrolithiasis evaluated at two
established stone centers. We found that 24-hour urinary
pH significantly decreases with increasing body weight.
This inverse relationship between urinary pH and body
weight was independent of gender, but was partly influ-
enced by age and urinary creatinine.
We would like to suggest that a possible explanation
for the progressive decline in urinary pH with increasing
body weight is insulin resistance, which decreases renal
ammonia excretion and impairs hydrogen ion buffering.
Experimental studies in vitro and in vivo have previously
demonstrated that insulin plays a critical role in renal am-
monia synthesis [20, 21] and excretion by the activation
of the sodium hydrogen exchanger 3 (NHE3) [22, 23].
Moreover, in human subjects with and without kidney
stones, we have also recently shown that insulin influ-
ences renal ammonium excretion [11]. Thus, low insulin
bioactivity (due to insulin resistance from obesity) in the
renal proximal tubule can theoretically lead to defective
ammonium production and/or excretion, and thus affect
urinary pH.
The above scheme is substantiated by our finding of
a strong inverse correlation between decreased disposal
rate of glucose (a measure of insulin resistance) and
24-hour urinary pH in normal subjects as well as in pa-
tients with uric acid stones [11]. It is also compatible with
the report that uric acid is much more commonly encoun-
tered as a stone constituent among diabetic patients with
stones than in a general population of patients with stones
[12]. Overall, the results suggest that insulin resistance
may be one of the important causes of gouty diathesis or
idiopathic uric acid nephrolithiasis.
Ingestion of a diet high in acid ash content (high animal
protein intake) is known to reduce urinary pH [24], due to
the generation of protons during the oxidation of sulfur in
animal proteins to sulfate [25]. In our study, the inverse re-
lationship between urinary pH and body weight persisted
after adjusting for urinary sulfate, a finding that supports
operation of a diet-independent mechanism. This conclu-
sion is in line with previous studies in idiopathic uric acid
nephrolithiasis, in which persistently low urinary pH was
found despite the use of a neutral ash diet [10, 11].
The pathophysiologic mechanism underlying the de-
cline in urinary pH with age may be the defective
ammonium excretion by the aging kidney [26, 27]. This as-
sociation was previously shown in a study of 300 healthy
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volunteers, in whom 24-hour urinary pH declined with
advancing age [28].
An unexpected finding in our study was the inverse
correlation between urinary creatinine and urinary pH.
Although at steady-state urinary creatinine excretion is a
good estimate of lean body mass [29, 30], it is also in part
affected by the dietary intake of animal protein [31]. In
this study, the inverse relationship between body weight
and urinary pH was maintained after adjustment for uri-
nary creatinine. This finding suggests that both lean body
mass and another mechanism, possibly body fat content,
might be involved in producing low urinary pH. This
interesting observation deserves further exploration in
future studies.
CONCLUSION
Body weight (a marker of peripheral insulin sensitiv-
ity) was shown to be inversely related to urinary pH
(a marker of renal insulin sensitivity) in a large popula-
tion of kidney stone formers. This relationship was found
to persist after adjustment for age and markers of dietary
indiscretion. The results support the previously postu-
lated scheme that obesity may sometimes cause uric acid
stones by producing renal insulin resistance that in turn
reduces urinary pH.
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